I think you'll find the desire of the USA Administration, is to (perhaps) lower the cost of older technologies, not recently approved new drugs (ie Sofdra), that would genuinely reduce innovation! Or that's the way the politics and industry negotiations will see things play out.....
BOT Price at posting:
40.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)